Organization | Serum Institute of India Pvt. Ltd.

Serum Institute of India Pvt. Ltd. Report issue

For profit Phase 1 Phase 3 Phase 4

Founded: Pune India (1966)

Status: No NME R&D (1966)

Organization Overview

First Clinical Trial

2012

NCT01557699

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

SERUM INSTITUTE OF INDIA | Serum Institute of India Pvt. Ltd.

Active Ingredients

Drugs in Phase 4 Trials (4)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (1 trial)

haemophilus influenzae type b conjugate vaccine (HibTITER) (1 trial)

measles, mumps, and rubella vaccine (MMR) (1 trial)

rabies vaccine adsorbed (BioRab) (2 trials)

Drugs in Phase 3 Trials (13)

bacille calmette-guerin (4 trials)

bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (2 trials)

brv-pv (Rotasil) (2 trials)

dipropyltryptamine (1 trial)

DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine (Pediarix) (1 trial)

Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant) (Comvax) (1 trial)

human rotavirus, live attenuated (Rotarix) (1 trial)

inactivated sabin strain polio virus (1 trial)

Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) (3 trials)

nmcv-5 (2 trials)

polio, inactivated poliovirus vaccine (Salk Vaccine) (1 trial)

rotavirus vaccine, live, oral, pentavalent (Rotateq) (2 trials)

yellow fever vaccine 17d strain (2 trials)

Drugs in Phase 1 Trials (3)

attenuated measles vaccine - Edmonston strain (rubeovax) (1 trial)

dengushield (1 trial)

dengusiil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Communicable Diseases (Phase 3)

Dengue (Phase 1)

Diarrhea (Phase 4)

Gastroenteritis (Phase 3)

Infections (Phase 3)

Latent Tuberculosis (Phase 3)

Measles (Phase 1)

Meningitis (Phase 3)

Meningitis, Meningococcal (Phase 3)

Meningococcal Infections (Phase 3)

Mycobacterium Infections (Phase 3)

Poliomyelitis (Phase 3)

Rabies (Phase 4)

Recurrence (Phase 3)

Respiration Disorders (Phase 4)

Respiratory Tract Diseases (Phase 4)

Tuberculosis (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 22
# of Trial APIs: 20